Boston Sci leads $10M round for Securus Medical

Securus Medical, which is developing a real-time thermal mapping system to measure core body temperature, raised $10 million in a Series C round led by Boston Scientific. The funding will go toward further product development and clinical investigation of its device.

The device, the infrared thermographic system (IRTS), recently received FDA clearance, the company said in a statement. It is an intrabody thermal measurement device intended for the continuous monitoring of esophageal temperature.

In addition to Boston Scientific, existing investors RiverVest Venture Partners, 3X5 Special Opportunity Fund and the University of Michigan’s Investment in New Technology Startups (MINTS) program also participated in the round.


Join the world's top medtech executives virtually for the leading event in medtech — The Virtual MedTech Conference by AdvaMed

Expect the same high-quality education, world-class speakers and valuable business development in a virtual format. Experience more of the conference with on demand content and partnering, as well as livestreamed sessions.

"This financing accelerates Securus Medical Group's technology development, and importantly it enables further validation of the Company's core technology which holds great potential to change the standard of care for esophageal temperature monitoring,” said Karen Spilizewski, RiverVest Venture Partners vice president and a Securus board member, in the statement.

The company previously raised $6.5 million in a 2013 Series B round.

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Galecto picked up $64 million to push its lead lung disease treatment toward an approval in Europe and fund midstage studies for its other programs.